Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Medication labelBuprenorphine and Naloxone Sublingual Tablets are indicated for the maintenance treatment of opioid dependence. Buprenorphine and Naloxone…
Why this: Advisory · dailymed-prescription
Buprenorphine and Naloxone Sublingual Tablets are indicated for the maintenance treatment of opioid dependence. Buprenorphine and Naloxone Sublingual Tablets should be used as part of a complete treatment plan to include counseling and psychosocial support.
- generic_name
- buprenorphine hydrochloride and naloxone hydrochloride dihydrate
- product_names
- buprenorphine hydrochloride and naloxone hydrochloride dihydrate
- ndc
- 51407-948, 51407-949, 0054-0188, 51407-948-30, 0054-0189, 51407-949-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en